{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T10:28:04Z","timestamp":1785234484169,"version":"3.55.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"42","license":[{"start":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T00:00:00Z","timestamp":1691539200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T00:00:00Z","timestamp":1691539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Environ Sci Pollut Res"],"DOI":"10.1007\/s11356-023-29134-z","type":"journal-article","created":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T11:02:31Z","timestamp":1691578951000},"page":"95660-95672","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["An insight into the hepatoprotective role of Velpatasvir and Sofosbuvir per se and in combination against carbon tetrachloride-induced hepatic fibrosis in rats"],"prefix":"10.1007","volume":"30","author":[{"given":"Sadaf","family":"Yasmeen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3490-799X","authenticated-orcid":false,"given":"Aslam","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fareeha","family":"Anwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Furqan","family":"Akhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidra","family":"Yasmeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shafeeq Ali","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,9]]},"reference":[{"key":"29134_CR1","doi-asserted-by":"publisher","unstructured":"Abbasi MH, Akhtar T, Malik IA, Fatima S, Khawar B, Mujeeb KA, Mustafa G, Hussain S, Iqbal J, Sheikh N (2013) Acute and chronic toxicity of thioacteamide and alterations in blood cell indices in rats. J Cancer Ther 4:1.\u00a0https:\/\/doi.org\/10.4236\/jct.2013.41032","DOI":"10.4236\/jct.2013.41032"},{"issue":"3","key":"29134_CR2","first-page":"321","volume":"89","author":"LZ Anna","year":"2018","unstructured":"Anna LZ, Monica M, Laura G (2018) Sofosbuvir\/Velpatasvir for the treatment of Hepatitis C Virus infection. Acta Bio Medica: Atenei Parmensis 89(3):321","journal-title":"Acta Bio Medica: Atenei Parmensis"},{"key":"29134_CR3","doi-asserted-by":"publisher","unstructured":"Bais S, Gill N, Kumar N (2015) Neuroprotective effect of Juniperus communis on chlorpromazine induced Parkinson disease in animal model. Chinese J Biol 2015 https:\/\/doi.org\/10.1155\/2015\/542542","DOI":"10.1155\/2015\/542542"},{"key":"29134_CR4","volume-title":"Theory and practice of histological techniques","author":"J Banchroft","year":"1996","unstructured":"Banchroft J, Stevens A, Turner D (1996) Theory and practice of histological techniques, 4th edn. Churchill Livingstone, New York, London, San Francisco, Tokyo","edition":"4"},{"key":"29134_CR5","doi-asserted-by":"publisher","unstructured":"Bhangale JO, Acharya SR (2016) Anti-Parkinson activity of petroleum ether extract of Ficus religiosa (L.) leaves. Adv Pharmacol Sci 2016 https:\/\/doi.org\/10.1155\/2016\/9436106","DOI":"10.1155\/2016\/9436106"},{"issue":"1","key":"29134_CR6","first-page":"001","volume":"58","author":"L Campana","year":"2017","unstructured":"Campana L, Iredale JP (2017) Regression of liver fibrosis. Seminars in Liver Disease 58(1):001\u2013010","journal-title":"Seminars in Liver Disease"},{"key":"29134_CR7","doi-asserted-by":"crossref","unstructured":"Cheng G, Yu M, Peng B, Lee Y-J, Trejo-Martin A, Gong R, Bush C, Worth A, Nash M, Chan K (2013) 1191 GS-5816, A second generation HCV NS5A inhibitor with potent antiviral activity, broad genotypic coverage and a high resistance barrier. J Hepatol (Suppl)484-485.\u00a0https:\/\/www.researchgate.net\/profile\/Michelle-Nash-3","DOI":"10.1016\/S0168-8278(13)61192-7"},{"key":"29134_CR8","doi-asserted-by":"crossref","first-page":"8082","DOI":"10.3748\/wjg.v20.i25.8082","volume":"20","author":"H Cicho\u017c-Lach","year":"2014","unstructured":"Cicho\u017c-Lach H, Michalak A (2014) Oxidative stress as a crucial factor in liver diseases. World J Gastroenterol: WJG 20:8082","journal-title":"World J Gastroenterol: WJG"},{"key":"29134_CR9","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1056\/NEJMoa1512614","volume":"373","author":"MP Curry","year":"2015","unstructured":"Curry MP et al (2015) Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis. N Engl J Med 373:2618\u20132628","journal-title":"N Engl J Med"},{"key":"29134_CR10","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1213\/01.ane.0000289638.26666.ed","volume":"106","author":"MT de Boer","year":"2008","unstructured":"de Boer MT, Christensen MC, Asmussen M, van der Hilst CS, Hendriks HG, Slooff MJ, Porte RJ (2008) The impact of intraoperative transfusion of platelets and red blood cells on survival after liver transplantation. Anesth Analg 106:32\u201344","journal-title":"Anesth Analg"},{"key":"29134_CR11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0009-9120(02)00287-4","volume":"35","author":"N Delibas","year":"2002","unstructured":"Delibas N, Ozcankaya R, Altuntas I (2002) Clinical importance of erythrocyte malondialdehyde levels as a marker for cognitive deterioration in patients with dementia of Alzheimer type: a repeated study in 5-year interval. Clin Biochem 35:137\u2013141","journal-title":"Clin Biochem"},{"key":"29134_CR12","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/jvh.13116","volume":"26","author":"H Dvory-Sobol","year":"2019","unstructured":"Dvory-Sobol H, Han B, Lu J, Yu M, Beran RK, Cheng G, Martin R, Svarovskaia E, Mo H (2019) In vitro resistance profile of hepatitis C virus NS5A inhibitor velpatasvir in genotypes 1 to 6. J Viral Hepat 26:991\u20131001","journal-title":"J Viral Hepat"},{"key":"29134_CR13","doi-asserted-by":"publisher","unstructured":"El-Sisi AE, Zakaria S (2019) Potential anti-fibrotic effect of direct acting antiviral drugs on CCl4 induced hepatic fibrosis in rats. Egypt J Basic Clin Pharmacol 9. https:\/\/doi.org\/10.32527\/2019\/101414","DOI":"10.32527\/2019\/101414"},{"key":"29134_CR14","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1111\/jgh.13758","volume":"32","author":"A Elsharkawy","year":"2017","unstructured":"Elsharkawy A, Alem SA, Fouad R, El Raziky M, El Akel W, Abdo M, Tantawi O, AbdAllah M, Bourliere M, Esmat G (2017) Changes in liver stiffness measurements and fibrosis scores following sofosbuvir based treatment regimens without interferon. J Gastroenterol Hepatol 32:1624\u20131630","journal-title":"J Gastroenterol Hepatol"},{"key":"29134_CR15","doi-asserted-by":"crossref","first-page":"17820","DOI":"10.1038\/s41598-020-74568-x","volume":"10","author":"O Etzion","year":"2020","unstructured":"Etzion O, Dahari H, Yardeni D, Issachar A, Nevo-Shor A, Cohen-Naftaly M, Ashur Y, Uprichard SL, Arbib OS, Munteanu D, Braun M, Cotler SJ, Abufreha N, Keren-Naus A, Shemer-Avni Y, Mor O, Murad J, Novack V, Shlomai A (2020) Response guided therapy for reducing duration of direct acting antivirals in chronic hepatitis C infected patients: a Pilot study. Sci Rep 10:17820","journal-title":"Sci Rep"},{"key":"29134_CR16","doi-asserted-by":"crossref","first-page":"818","DOI":"10.7326\/M15-1000","volume":"163","author":"GT Everson","year":"2015","unstructured":"Everson GT, Towner WJ, Davis MN, Wyles DL, Nahass RG, Thuluvath PJ, Etzkorn K, Hinestrosa F, Tong M, Rabinovitz M (2015) Sofosbuvir with velpatasvir in treatment-naive noncirrhotic patients with genotype 1 to 6 hepatitis C virus infection: a randomized trial. Ann Intern Med 163:818\u2013826","journal-title":"Ann Intern Med"},{"key":"29134_CR38","unstructured":"Fattah A, Nehal K, Shaheen S, Ahmed O, Elsaeed K, Sabri N (2022) Metabolic changes in chronic hepatitis C patients receiving direct acting antivirals"},{"key":"29134_CR17","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1056\/NEJMoa1512610","volume":"373","author":"JJ Feld","year":"2015","unstructured":"Feld JJ et al (2015) Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection. N Engl J Med 373:2599\u20132607","journal-title":"N Engl J Med"},{"key":"29134_CR18","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/apt.15476","volume":"50","author":"JJ Freriksen","year":"2019","unstructured":"Freriksen JJ, van Seyen M, Judd A, Gibb DM, Collins IJ, Greupink R, Russel FG, Drenth JP, Colbers A, Burger DM (2019) direct-acting antivirals for the treatment of HCV during pregnancy and lactation-implications for maternal dosing, foetal exposure, and safety for mother and child. Aliment Pharmacol Ther 50:738\u2013750","journal-title":"Aliment Pharmacol Ther"},{"key":"29134_CR19","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1515\/jtim-2017-0007","volume":"5","author":"A Geddawy","year":"2017","unstructured":"Geddawy A, Ibrahim YF, Elbahie NM, Ibrahim MA (2017) Direct Acting Anti-hepatitis C Virus Drugs: Clinical Pharmacology and Future Direction. J Transl Int Med 5:8\u201317","journal-title":"J Transl Int Med"},{"key":"29134_CR20","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0009-8981(91)90067-M","volume":"196","author":"L Goth","year":"1991","unstructured":"Goth L (1991) A simple method for determination of serum catalase activity and revision of reference range. Clin Chim Acta 196:143\u2013151","journal-title":"Clin Chim Acta"},{"key":"29134_CR21","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1007\/s40265-016-0648-2","volume":"76","author":"SL Greig","year":"2016","unstructured":"Greig SL (2016) Sofosbuvir\/Velpatasvir: A Review in Chronic Hepatitis C. Drugs 76:1567\u20131578","journal-title":"Drugs"},{"key":"29134_CR22","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2337\/diaclin.23.3.115","volume":"23","author":"EH Harris","year":"2005","unstructured":"Harris EH (2005) Elevated liver function tests in type 2 diabetes. Clin Diabetes 23:115\u2013119","journal-title":"Clin Diabetes"},{"key":"29134_CR23","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.neuropharm.2018.09.039","volume":"143","author":"X Huang","year":"2018","unstructured":"Huang X, Xiaokaiti Y, Yang J, Pan J, Li Z, Luria V, Li Y, Song G, Zhu X, Zhang H-T (2018) Inhibition of phosphodiesterase 2 reverses gp91phox oxidase-mediated depression-and anxiety-like behavior. Neuropharmacology 143:176\u2013185","journal-title":"Neuropharmacology"},{"key":"29134_CR24","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/nbm.1030","volume":"19","author":"L Huwart","year":"2006","unstructured":"Huwart L, Peeters F, Sinkus R, Annet L, Salameh N, ter Beek LC, Horsmans Y, Van Beers BE (2006) Liver fibrosis: non-invasive assessment with MR elastography. NMR Biomed: Int J Devoted Dev Appl Magnet Resonance in Vivo 19:173\u2013179","journal-title":"NMR Biomed: Int J Devoted Dev Appl Magnet Resonance in Vivo"},{"key":"29134_CR25","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/17474124.2017.1326817","volume":"11","author":"WE Jackson","year":"2017","unstructured":"Jackson WE, Everson GT (2017) Sofosbuvir and velpatasvir for the treatment of hepatitis C. Expert Rev Gastroenterol Hepatol 11:501\u2013505","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"29134_CR26","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nature04870","volume":"441","author":"M Karin","year":"2006","unstructured":"Karin M (2006) Nuclear factor-\u03baB in cancer development and progression. Nature 441:431\u2013436","journal-title":"Nature"},{"key":"29134_CR27","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s40265-014-0179-7","volume":"74","author":"GM Keating","year":"2014","unstructured":"Keating GM, Vaidya A (2014) Sofosbuvir: first global approval. Drugs 74:273\u2013282","journal-title":"Drugs"},{"key":"29134_CR28","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1742-7843.2007.00152.x","volume":"104","author":"KW Kim","year":"2009","unstructured":"Kim KW, Suh SJ, Kim JD, Kim SS, Lee IS, Kim JK, Chang GT, Kim DS, Kim CH (2009) Effects on lipid peroxidation and antioxidative enzymes of Euonymus alatus in cultured rat hepatocytes. Basic Clin Pharmacol Toxicol 104:60\u201370","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"29134_CR29","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","volume":"18","author":"T Kisseleva","year":"2021","unstructured":"Kisseleva T, Brenner D (2021) Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol 18:151\u2013166","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"29134_CR30","unstructured":"Lala V, Zubair M, Minter DA (2022) Liver function tests.[Updated 2022 Oct 5]. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL). https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK482489"},{"key":"29134_CR31","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1038\/labinvest.2010.123","volume":"90","author":"C Liu","year":"2010","unstructured":"Liu C, Tao Q, Sun M, Wu JZ, Yang W, Jian P, Peng J, Hu Y, Liu C, Liu P (2010) Kupffer cells are associated with apoptosis, inflammation and fibrotic effects in hepatic fibrosis in rats. Lab Invest 90:1805\u20131816","journal-title":"Lab Invest"},{"key":"29134_CR32","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3350\/cmh.2017.0078","volume":"23","author":"RC Lo","year":"2017","unstructured":"Lo RC, Kim H (2017) Histopathological evaluation of liver fibrosis and cirrhosis regression. Clin Mol Hepatol 23:302","journal-title":"Clin Mol Hepatol"},{"key":"29134_CR33","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265\u2013275","journal-title":"J Biol Chem"},{"key":"29134_CR34","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/112_2018_10","volume":"175","author":"T Luangmonkong","year":"2018","unstructured":"Luangmonkong T, Suriguga S, Mutsaers HA, Groothuis GM, Olinga P, Boersema M (2018) Targeting oxidative stress for the treatment of liver fibrosis. Rev Physiol Biochem Pharmacol 175:71\u2013102","journal-title":"Rev Physiol Biochem Pharmacol"},{"key":"29134_CR35","volume-title":"Effect of antiviral therapy for HCV on lipid levels","author":"S Mauss","year":"2017","unstructured":"Mauss S, Berger F, Wehmeyer MH, Ingiliz P, Hueppe D, Lutz T, Simon KG, Schewe K, Rockstroh JK, Baumgarten A (2017) Effect of antiviral therapy for HCV on lipid levels. SAGE Publications Sage UK, London, England"},{"key":"29134_CR36","doi-asserted-by":"crossref","first-page":"248S","DOI":"10.1111\/j.1530-0277.1998.tb04011.x","volume":"22","author":"CJ McClain","year":"1998","unstructured":"McClain CJ, Barve S, Barve S, Deaciuc I, Hill DB (1998) Tumor necrosis factor and alcoholic liver disease. Alcoholism: Clin Exper Res 22:248S-252S","journal-title":"Alcoholism: Clin Exper Res"},{"key":"29134_CR37","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/apt.12300","volume":"37","author":"L Nguyen","year":"2013","unstructured":"Nguyen L, Nguyen M (2013) Systematic review: Asian patients with chronic hepatitis C infection. Aliment Pharmacol Ther 37:921\u2013936","journal-title":"Aliment Pharmacol Ther"},{"key":"29134_CR39","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/lt.21510","volume":"14","author":"IT Pereboom","year":"2008","unstructured":"Pereboom IT, Lisman T, Porte RJ (2008) Platelets in liver transplantation: friend or foe? Liver Transpl 14:923\u2013931","journal-title":"Liver Transpl"},{"key":"29134_CR40","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0098-2997(00)00004-2","volume":"21","author":"G Poli","year":"2000","unstructured":"Poli G (2000) Pathogenesis of liver fibrosis: role of oxidative stress. Mol Aspects Med 21:49\u201398","journal-title":"Mol Aspects Med"},{"key":"29134_CR41","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/252234a0","volume":"252","author":"GM Powell","year":"1974","unstructured":"Powell GM, Miller J, Olavesen A, Curtis C (1974) Liver as major organ of phenol detoxication? Nature 252:234\u2013235","journal-title":"Nature"},{"key":"29134_CR42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/bph.12291","volume":"171","author":"T Rassaf","year":"2014","unstructured":"Rassaf T, Ferdinandy P, Schulz R (2014) Nitrite in organ protection. Br J Pharmacol 171:1\u201311","journal-title":"Br J Pharmacol"},{"key":"29134_CR43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12876-022-02469-6","volume":"22","author":"B Rauff","year":"2022","unstructured":"Rauff B, Alzahrani B, Chudhary SA, Nasir B, Mahmood S, Bhinder MA, Faheem M, Amar A (2022) PNPLA3 and TM6SF2 genetic variants and hepatic fibrosis and cirrhosis in Pakistani chronic hepatitis C patients: a genetic association study. BMC Gastroenterol 22:1\u201310","journal-title":"BMC Gastroenterol"},{"key":"29134_CR44","doi-asserted-by":"crossref","first-page":"e31183","DOI":"10.1097\/MD.0000000000031183","volume":"101","author":"XD Ren","year":"2022","unstructured":"Ren XD, Fu X, He YQ, Li CY, Guo M, Qiao M (2022) Safety and efficacy of sofosbuvir-velpatasvir: A meta-analysis. Medicine (baltimore) 101:e31183","journal-title":"Medicine (baltimore)"},{"key":"29134_CR45","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.jhep.2016.02.004","volume":"64","author":"D Schmidt-Arras","year":"2016","unstructured":"Schmidt-Arras D, Rose-John S (2016) IL-6 pathway in the liver: from physiopathology to therapy. J Hepatol 64:1403\u20131415","journal-title":"J Hepatol"},{"key":"29134_CR46","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/jhbp.245","volume":"22","author":"E Seki","year":"2015","unstructured":"Seki E, Brenner DA (2015) Recent advancement of molecular mechanisms of liver fibrosis. J Hepatobiliary Pancreat Sci 22:512\u2013518","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"29134_CR47","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/mp.2016.23","volume":"22","author":"S Shah","year":"2017","unstructured":"Shah S, Yoon G, Chung S, Abid M, Kim T, Lee H, Kim M (2017) Novel osmotin inhibits SREBP2 via the AdipoR1\/AMPK\/SIRT1 pathway to improve Alzheimer\u2019s disease neuropathological deficits. Mol Psychiatry 22:407\u2013416","journal-title":"Mol Psychiatry"},{"key":"29134_CR48","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/hep.21347","volume":"44","author":"R Williams","year":"2006","unstructured":"Williams R (2006) Global challenges in liver disease. Hepatology 44:521\u2013526","journal-title":"Hepatology"},{"key":"29134_CR49","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/hep.23312","volume":"51","author":"VWS Wong","year":"2010","unstructured":"Wong VWS, Vergniol J, Wong GLH, Foucher J, Chan HLY, Le Bail B, Choi PCL, Kowo M, Chan AWH, Merrouche W (2010) Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology 51:454\u2013462","journal-title":"Hepatology"},{"key":"29134_CR50","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/jgh.15324","volume":"36","author":"YJ Wong","year":"2021","unstructured":"Wong YJ, Thurairajah PH, Kumar R, Tan J, Fock KM, Law NM, Li W, Kwek A, Tan YB, Koh J, Lee ZC, Kumar LS, Teo EK, Ang TL (2021) Efficacy and safety of sofosbuvir\/velpatasvir in a real-world chronic hepatitis C genotype 3 cohort. J Gastroenterol Hepatol 36:1300\u20131308","journal-title":"J Gastroenterol Hepatol"},{"key":"29134_CR51","doi-asserted-by":"crossref","first-page":"318","DOI":"10.2174\/1874467213666200116114919","volume":"13","author":"S Zakaria","year":"2020","unstructured":"Zakaria S, El-Sisi AE (2020) Daclatasvir and Sofosbuvir Mitigate Hepatic Fibrosis Through Down-regulation of TNF-\u03b1\/NF-\u039aB Signaling Pathway. Curr Mol Pharmacol 13:318\u2013327","journal-title":"Curr Mol Pharmacol"}],"container-title":["Environmental Science and Pollution Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11356-023-29134-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11356-023-29134-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11356-023-29134-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T19:31:29Z","timestamp":1702927889000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11356-023-29134-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,9]]},"references-count":51,"journal-issue":{"issue":"42","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["29134"],"URL":"https:\/\/doi.org\/10.1007\/s11356-023-29134-z","relation":{},"ISSN":["1614-7499"],"issn-type":[{"value":"1614-7499","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,9]]},"assertion":[{"value":"17 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal study, along with experimental protocols, was approved by the Research Ethical Committee of Riphah International University Lahore (REC\/RIPS-LHR) with the reference number REC\/RIPS-LHR\/2022\/060.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not Applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"I; Dr. Aslam Khan, give my consent for information about the text; pictures published in the article will be freely available to the public when it is published.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare that they have no conflict of interest.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}